A research team at Kintor Pharmaceutical in China has announced that the Phase 3 clinical trial of the topical androgen receptor antagonist pyrilutamide (KX-826) has met its primary endpoint. While ...

While dutasteride shows efficacy against androgenetic alopecia, consideration for side effects is necessary. We will examine how it differs from the conventional drug finasteride and how reliable it ...